How Do I Sell Medical Devices in the Netherlands?
Navigate Netherlands medical device regulations, CE marking, and distribution channels for successful market entry.
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 253–261 of 396
Navigate Netherlands medical device regulations, CE marking, and distribution channels for successful market entry.
FDA approval does not automatically allow you to sell medical devices in Europe. The US and European systems operate independently, with different regulatory bodies, approval processes, and legal requirements. To market your device in Europe, you must obtain CE marking through a separate conformity assessment process. However, your FDA documentation—including clinical data, design verification, and quality management systems—can significantly support your European submission, potentially reducing your market entry timeline by several months while addressing Europe-specific requirements.
Getting your medical device approved for Europe means achieving CE marking compliance under the Medical Device Regulation (MDR). Unlike FDA approval, Europe uses a conformity assessment approach where you demonstrate compliance through technical documentation, risk management, and quality systems. The process varies by device classification—from 3-6 months for Class I self-certification to 9-18 months for Class III devices requiring notified body assessment. Non-EU manufacturers must designate a European Authorized Representative to serve as their legal regulatory contact before market entry.
Selling medical devices in Europe requires navigating CE marking, appointing an authorised representative, and meeting MDR/IVDR compliance standards. Non-EU manufacturers must establish local regulatory presence, register devices in EUDAMED, and implement UDI requirements. Understanding classification systems, conformity assessments, and post-market surveillance obligations helps you avoid costly compliance mistakes and streamline your European market entry strategy.
Europe doesn't require traditional pre-market approval for medical devices. Instead, manufacturers demonstrate conformity with the Medical Device Regulation (MDR) through self-certification, obtain CE marking, and maintain ongoing compliance. The process varies by device classification—Class I devices may achieve market readiness in 3-6 months, while higher-risk devices requiring Notified Body certification can take 12-24 months. Success depends on understanding conformity assessment procedures, preparing comprehensive technical documentation, implementing ISO 13485 quality systems, and establishing post-market surveillance.
American medical devices can enter European markets, but FDA approval alone isn't enough. You'll need CE marking certification, an EU Authorised Representative, and full compliance with Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR) requirements. The process involves device classification, technical documentation, conformity assessment through Notified Bodies, and EUDAMED registration. Unlike the FDA's centralized pre-market review, European regulations emphasize manufacturer responsibility and post-market surveillance throughout your device's lifecycle. Understanding these distinct requirements helps you plan timelines, resources, and partnerships for successful European market entry.
Learn proven regulatory risk management strategies for medical device companies navigating complex compliance across multiple markets.
Learn systematic regulatory risk management for medical devices and ensure patient safety through compliance.
Swiss authorized representative services cost €3,000-€8,000 annually plus setup fees. Get accurate pricing insights here.
Showing 253–261 of 396